Medicare lab test price cuts mandated by the Protecting Access to Medicare Act (PAMA) are eroding the finances of urology groups that do in-office clinical laboratory testing. In the November issue of Urology Times, urologist Robert A. Dowling, MD, wrote a news story that identified the cuts in Medicare Part B prices for the lab tests
Tag: dna testing
CEO SUMMARY: When pathology labs discover instances of a misidentified or contaminated tissue specimen, there is a new service that allows them to retrospectively use DNA to properly match that specimen to the correct patient. In part two of our series, we look at how some pathology labs are using the Know Error service to
CEO SUMMARY: Prevention of diagnostic testing errors is getting more attention by both physicians and pathology labs because patients are less tolerant of potentially life-changing errors. Strand Diagnostics’ Know Error system is designed to reduce or eliminate errors involving tissue specimen misidentification. In this first part of our two-part series, we provide information about the
CEO SUMMARY: One intrepid medical technologist has spent almost two decades in volunteer service working in the clinical laboratories of hospital ships operated by Mercy Ships International. As the world’s largest hospital ship, the Africa Mercy contains six operating rooms, a 78-bed ICU and patient ward, along with a clinical lab that is equipped with
Expanded genetic testing for cancer patients in the United Kingdom is one goal of a new effort by the Stratified Medicine Programme at Cancer Research UK. Officials want to ensure that the right genetic tests are available to support use of new therapeutic drugs for different types of cancer. The project will start in Wales
In response to continuing requests by clients and readers of THE DARK REPORT, this issue institutes a new feature titled “Lab Fraud Watch.” It will provide information about activities in the medical laboratory testing marketplace which could be interpreted as violating federal and state fraud and abuse laws.
It is the belief of many lab executives
LAB MEETINGS CONTINUE WITH STRONG ATTENDANCE
DESPITE THE HASSLES that now come with cross-country travel, laboratorians throughout the United States continue to support industry meetings.
Traditionally the largest lab meeting of the fall season, “Lab Institute 2001” expects good attendance. Dennis Weissman, Publisher of Washington G- 2 Intelligence Reports and producer of the conference, tells THE DARK
CEO SUMMARY: DNA testing will be a primary tool in identifying victims of this major disaster. Officials in New York City are formulating a plan whereby private labs will do DNA testing in conjunction with New York State Police laboratories. Laboratory Corporation of America has been designated as a public collection site where victim’s family
FEDERAL ATTORNEY SERVES SUBPOENA ON DIANON SYSTEMS
NEWS BROKE LAST WEEK that DIANON Systems, Inc. had received a subpoena from the U.S. Attorney’s Office in Connecticut for documents relating to laboratory billing.
Apparently “LabScam” is still alive and well within the Department of Justice. LabScam is the OIG’s code word for its extensive investigations into claims of